Company: LHI
Filing Date: 2025-02-14
Form Type: DRS/A
Source: 0001213900-25-014190
Chunk: 212

Company: Living Homeopathy International Ltd.
Filing Date: 2025-02-14
Form: DRS/A
Chunk 212
---
. However, it is anticipated that our Company may remain out of scope of the legislation or else be subject to more limited substance requirements.

<div align='center'>120

SHARES ELIGIBLE FOR FUTURE SALE</div>

Before Living Homeopathy’s initial public offering, there has not been a public market for Living Homeopathy’s Class A Ordinary Shares, and although the Company intends to apply for listing on the Nasdaq Capital Market, a regular trading market for Living Homeopathy’s Class A Ordinary Shares may not develop. Future sales of substantial amounts of Living Homeopathy’s Class A Ordinary Shares in the public market after Living Homeopathy’s initial public offering, or the possibility of these sales occurring, could cause the prevailing market price for Living Homeopathy’s Class A Ordinary Shares to fall or impair Living Homeopathy’s ability to raise equity capital in the future. Upon completion of this offering, the Company will have [●] Class A Ordinary Shares issued and outstanding. All of the Class A Ordinary Shares sold in this offering will be freely transferable by persons other than Living Homeopathy’s “affiliates” without restriction or further registration under the Securities Act.

Lock-Up Agreements

The Company has agreed to enter into a customary lock-up agreement for a period of six (6) months from the date of the offering, subject to certain exceptions, among others, with respect to any shares of capital stock of the Company or any securities convertible or exchangeable for shares of capital stock of the Company, without the prior written consent of the representatives of the Underwriters. See “Underwriting” beginning on page 129 of this prospectus for more information.

Furthermore, each of Living Homeopathy’s directors, executive officers, and principal shareholders (5% or more shareholders) of the Company’s outstanding share capital has also agreed to enter into a similar lock-up agreement for a period of six (6) months from the date of the offering, subject to certain exceptions, with respect to any shares of capital stock of the Company or any securities convertible or exchangeable for shares of capital stock of the Company, without the prior written consent of the representatives of the Underwriters. See “Underwriting” beginning on page 129 of this prospectus for more information.

The Company is not aware of any plans by any significant shareholders to dispose of significant numbers of the Company’s Ordinary Shares. However, one or more existing shareholders or owners of securities convertible or exchangeable into or exercisable for the Company’s Ordinary Shares may dispose of significant numbers of the Company’s Ordinary Shares in